KESHAV
EUR 216.67
1,000+ verkauftStationaere Apotheke in Hongkong, 100% Echtheitsgarantie
Anamorelin, a prescription medicine targeting the ghrelin receptor GHS-R1a, was approved in Japan in January 2021 and launched in April of the same year. Use it only as directed by a physician.
10000 vorrätig
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Anamorelin Wirkweise Wirkweise ，
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indikationen
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Wirkmechanismus
Anamorelin Wirkweise Wirkweise ，
Dosierung
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
Vorsichtshinweise
EMA Refused - No
